Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 3:46 PM
Ignite Modification Date:
2025-12-24 @ 3:46 PM
NCT ID:
NCT04346992
Brief Summary:
Hormonal imbalances are likely to affect the corneal metabolism and may be also associated with Keratoconus. Among the various endocrinologic dysfunctions assumed so far, thyroid gland dysfunction (TGD) (hypo- or hyperthyroidism; comprised as TGD) is frequently associated with eye diseases such as Graves disease
Detailed Description:
Aim of the work
We aim to examine the prevalence of KC among patients already diagnosed by endocrinologist with TGD.
Materials and methods
Our Screening for KC will include evaluation of the demographic data and complete ophthalmological examination of the patients using:
VA Refraction K reading Slit lamp examination Pentacam Study design Epidemiological study
Inclusion citeria All patients diagnosed as thyroid gland dysfunction Control group
Exclusion criteria Uncooperative patients
Study:
NCT04346992
Study Brief:
Protocol Section:
NCT04346992